Forian (FORA) Stock Overview
Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
FORA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Forian Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.15 |
| 52 Week High | US$4.03 |
| 52 Week Low | US$1.64 |
| Beta | 1.03 |
| 1 Month Change | -6.93% |
| 3 Month Change | 11.42% |
| 1 Year Change | 6.44% |
| 3 Year Change | -37.68% |
| 5 Year Change | n/a |
| Change since IPO | -90.61% |
Recent News & Updates
Recent updates
Health Check: How Prudently Does Forian (NASDAQ:FORA) Use Debt?
Aug 24
Investors Aren't Entirely Convinced By Forian Inc.'s (NASDAQ:FORA) Revenues
Jul 02There's Reason For Concern Over Forian Inc.'s (NASDAQ:FORA) Massive 30% Price Jump
Feb 12
Integration Of Kyber Data Science Will Provide Differentiated Value To Customers
The acquisition of Kyber Data Science and strategic partnerships are expected to enhance market reach and shareholder value, driving revenue growth.The Consensus EPS Estimates For Forian Inc. (NASDAQ:FORA) Just Fell A Lot
Aug 18Forian (NASDAQ:FORA) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 05Unpleasant Surprises Could Be In Store For Forian Inc.'s (NASDAQ:FORA) Shares
Apr 03Is Forian (NASDAQ:FORA) Using Too Much Debt?
Feb 27Investors Give Forian Inc. (NASDAQ:FORA) Shares A 28% Hiding
May 05Shareholder Returns
| FORA | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -4.0% | -3.7% | -2.0% |
| 1Y | 6.4% | 8.0% | 12.1% |
Return vs Industry: FORA matched the US Healthcare Services industry which returned 7% over the past year.
Return vs Market: FORA underperformed the US Market which returned 12.1% over the past year.
Price Volatility
| FORA volatility | |
|---|---|
| FORA Average Weekly Movement | 10.6% |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FORA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: FORA's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 48 | Max Wygod | forian.com |
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company’s subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
Forian Inc. Fundamentals Summary
| FORA fundamental statistics | |
|---|---|
| Market cap | US$66.89m |
| Earnings (TTM) | -US$906.26k |
| Revenue (TTM) | US$25.03m |
Is FORA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FORA income statement (TTM) | |
|---|---|
| Revenue | US$25.03m |
| Cost of Revenue | US$10.18m |
| Gross Profit | US$14.85m |
| Other Expenses | US$15.75m |
| Earnings | -US$906.26k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 14, 2025
| Earnings per share (EPS) | -0.029 |
| Gross Margin | 59.32% |
| Net Profit Margin | -3.62% |
| Debt/Equity Ratio | 22.0% |
How did FORA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/09 04:42 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Forian Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Baldry | Roth Capital Partners |